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Gap junctions are intercellular channels which directly connect the cytoplasm between neighboring cells. In the central nervous system
(CNS) various kinds of cells are coupled by gap junctions, which play an important role in maintaining normal function. Neuronal gap
junctions are involved in electrical coupling and may also contribute to the recovery of function after cell injury. Astrocytes are involved in
the pathology of most neuronal disorders, including brain ischemia, Alzheimer’s disease and epilepsy. In the pathology of brain tumors, gap
junctions may be related to the degree of malignancy and metastasis. However, the role of connexins, gap junctions and hemichannels in the
pathology of the diseases in the CNS is still ambiguous. Of increasing importance is the unraveling of the function of gap junctions in the
neural cell network, involving neurons, astrocytes, microglia and oligodendrocytes. A better understanding of the role of gap junctions may
contribute to the development of new therapeutic approaches to treating diseases of the CNS.
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The gap junction is the site of the intercellular membrane
channels which provide for direct cytoplasmic continuity
between adjacent cells [1]. The structural unit of the gap
junction is the connexon, a proteinaceous cylinder with a
hydrophilic channel. They span the plasma membranes of
closely apposed cells to align end-to-end, forming intercel-
lular channels which provide for the exchange of small
molecules (less than 1200 Da). The gap junction protein,
connexin (Cx), is encoded by a multi-gene family consisting
of at least 20 members in mammals [1]. Several connexins
exhibit a characteristic tissue and cellular distribution in the
adult animal, and many tissues and cells have been shown to
express multiple connexins. Eleven subtypes are found in
the central nervous system (CNS). The subset and the
expression of connexins vary depending on the type of cell
and the stage of development [2] (see Table 1 for details of
cellular expression in the CNS).
The CNS is mainly composed of neurons and glial cells
such as astrocytes, microglia and oligodendrocytes. Neurons
are interconnected by axons and dendrites and play an0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: cnaus@interchange.ubc.ca (C.C.G. Naus).important role in transmitting signals through synaptic
interactions. Astrocytes have many processes and compose
an astrocytic syncitium which provides physical and meta-
bolic support of neurons. Microglia are CNS residential
macrophages and play a role in the immune response of the
CNS. Oligodendrocytes form myelin sheaths which sur-
rounds neuronal axons, providing acceleration of the con-
duction process in the neuronal axons.
In the nervous system, intercellular coupling via gap
junctions occurs between neurons, astrocytes, oligodendro-
cytes, microglia and ependymal cells [3–5] as well as
between different cell types, such as neuron–astrocyte [6]
and astrocyte–oligodendrocyte [3,4]. The non-neuronal
junctions presumably play a role in ion transfer and meta-
bolic cooperation. Expression of multiple connexins has
been demonstrated in the CNS (Table 1) [7]. Given the
heterogeneous composition of brain tissue, some of this
expression is likely accounted for by endothelial cells which
are known to express Cx37 [8] and Cx40 [9], as well as
Cx43 [10], and meningeal cells which express Cx43 and
Cx26 [11]. However, the expression of many of these
connexins remains to be determined at the cellular level.
Neurological disorders can be classified into two groups:
the peripheral nervous system (PNS) diseases and the CNS
diseases. Several studies have noted the involvement of gap
junctions in CNS disorders, including cerebrovascular dis-
Table 1
Connexin subtype and cellular expression in the CNS
Connexin subtype Cell type (expressed stage) References
26 neuron [29,30,35]
astrocyte [73]
29 oligodendrocyte [101]
30 astrocyte (matured) [3,72]
32 neuron (matured) [32]
oligodendrocyte [95–100]
36 neuron [34,36,37]
oligodendrocyte [5]
microglia [5]
37 neuron [39]
40 neuron (developing) [39]
astrocyte [73]
43 neuron (mainly developing) [29,32]
astrocyte [70,71]
microglia (activated) [91,92]
45 neuron [40,63]
astrocyte [73]
46 astrocyte [73]
47 neuron [38]
astrocyte [2]
oligodendrocyte [102]
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neurodegenerative diseases such as Alzheimer’s disease and
Parkinson’s disease [15,16], epilepsy [17,18] and brain
tumors [19,20]. In this review, possible functions of gap
junctions and hemichannels, which are composed of a single
connexon opened to the extracellular space, will be de-
scribed separately in each of the cell types of the CNS, and
the role of the hemichannels and gap junctions in various
neurological diseases will be discussed.
Table 2
The observed abnormalities in connexin knockout mice
Knockout mouse Abnormalities References
Cx26 embryonal lethal [61]
(Cx26fl/fl, Otog-cre) hearing impairment [62]
Cx30 severe hearing impairment [89]
Cx32 demyelination in PNS [55,56]
hyperexcitability in CNS [57]
enhanced neuronal
injury in ischemia
[124]
Cx36 visual deficit [59]
synchronization defect
in hippocampus
[60]
disturbed synchronous
inhibitory activity
[41]
disrupted gamma frequency
oscillations in cortex
[42]
Cx43 neonatal lethal [51]
subtle neural changes in embryo [50]
neural crest migration defect [52,53]
disturbance of neural
migration in embryonic neocortex
[54]
(Cx43 +/ ) enhanced neuronal injury in ischemia [87,117]
(Cx43fl/fl,GFAP-cre) increased spreading depression
in hippocampus
enhanced neuronal injury in ischemia
[88]
Cx45 embryonic lethal [63]
Cx47 vacuolation in nerve fibers [102]
(Cx47/32 double) severe demyelination in CNS [102,112]2. Gap junctions in the cells of the nervous system
2.1. Neurons
Electrotonic coupling between mammalian neurons has
been shown in many areas of the CNS and has been
implicated in neuronal synchronization [21–24]. During
development, there is a high degree of intercellular coupling
between neurons. Studies in the rat indicate that neuroblasts
are coupled with approximately 30–60 others in columns
within the ventricular zone of the developing cerebral cortex
[25–28]. The zone is comprised of mitotically active epi-
thelial cells lining the ventricles. These cells have been
shown to express Cx43 and Cx26 [29], and the coupling
appears to involve both neural precursors and radial glia
[30]. Thus gap junctional intercellular communication
(GJIC) may establish cortical domains in the developing
neocortex that underlie the adult pattern of functional archi-
tecture [27,28,31]. Although Cx43 has been reported in
neurons of the cortical plate, the expression of Cx32 in
mature neurons [32] is controversial [33,34]. The expression
pattern of Cx26 [35] and Cx36 [36,37] in the developing
brain is more consistent with the transient gap junctionalcoupling observed in the neocortex. In addition, Cx47 is also
observed in the CNS [38], but its expression seems to be
different from that of Cx36 in neurons of developing CNS,
but there is some co-localization with Cx36 in cerebellum
[38]. Cx37 is observed in motor neurons and Cx40 is
expressed in developing neurons of spinal cord [39].
In the adult CNS, neurons are coupled via gap junctions
mainly composed of Cx36 [34] and Cx45 [40] in the cortex
and hippocampus. These neuronal gap junctions play an
important role in forming electrical synapses [41,42]. Cx45
is expressed widely in the developing brain and in the adult
brain localized in cerebral cortex, hippocampus and thala-
mus [40]. Cx45 is also observed in olfactory nerves [43]. In
the retina, Cx26 is expressed in horizontal cells [44] and
Cx36 in AII amacrine cells [45], although Cx26 is not
shown in the neurons in the adult cortex and hippocampus
[46]. Recently, it has been reported that hemichannels of
horizontal cells in the retina are mainly composed of Cx26
and regulate the activity of the Ca2 + channels and subse-
quent glutamate release [44]. The availability of various
antibodies has made it possible to detect connexins which
compose gap junctions [34,47] as well as hemichannels
[48,49], allowing characterization of the functional state,
distribution and co-localization of connexins.
In order to understand the role of specific connexins in the
CNS, a knockout strategy has been employed by several
investigators (see Table 2 for summary). Initial examination
suggested some subtle neural changes may be apparent in the
Cx43 knockout mice at birth [50]. However, the neural
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cardiac malformation and neonatal death [51]. In these mice,
the abnormal migration of neural crest was observed [52,53].
More recently, we have reported a disturbance in the migra-
tion of neurons in the neocortex of the Cx43 null mice [54].
Cx32 knockout mice are viable and fertile, and display
demylenation in the PNS [55,56]. Moreover, neuronal hy-
perexcitability and myelin defects in the neocortex were
observed [57], and the accumulation of oligodendrocyte
progenitor cells and amplified apoptosis has been reported
in the CNS of Cx32 knockout mice [58]. Cx36 knockout
mice are viable and display no obvious anatomical abnor-
malities [59], however detailed neurodevelopmental and
anatomical studies have not been reported. Studies using
Cx36 knockout mice in vitro suggest that the neuronal gap
junctions are critical in the formation of gamma frequency
oscillations in the hippocampus [42] and in generating
synchronous activity in the cortex [41]. These mice show
selective impairment of hippocampal gamma oscillations
[60]. Knockout of the other neuronal candidate, Cx26, is
lethal at E9–10 [61], and thus additional strategies must be
followed to investigate its function in neuronal development
[62]. Cx45 knockout mice die at E8–9 due to abnormal
vascular development. Therefore, it is impossible to study
the gap junctional function using adult Cx45 knockout mice.
The expression of Cx45 has also been reported in the
embryonic cortex and hippocampus [63], but its role in the
development of the CNS remains to be determined.
In vitro studies have suggested a role for gap junctional
coupling in neuronal differentiation. When NT2 human
embryonal carcinoma cells differentiate into neurons in
response to retinoic acid (RA), the expression of Cx43, and
the level of gap junctional coupling, progressively disappear
[64]. Blocking of gap junctions disrupts RA-induced neuro-
nal differentiation of both human NT2 [65] and mouse P19
cells [66]. Moreover, the differentiation of NT2/D1 progen-
itor cells are reduced by blocking of gap junctions and
hemichannels, suggesting hemichannels also play a role in
the neuronal differentiation [67]. It therefore appears that the
temporal pattern of connexin expression and gap junctional
coupling during neuronal differentiation is critical.
2.2. Astrocytes
The main cell type in the brain coupled by gap junctions
is the astrocyte. Astrocytes have traditionally been viewed
to have a role in the metabolic and trophic support of
neurons [68]. Intimate interactions have been shown to be
involved in the role of radial glia in directing migration of
neurons in the cortex [69]. Indeed, gap junctional coupling
between radial glia and neural precursors may be critical for
this process [30]. Gap junctions in astrocytes are primarily
composed of Cx43 [70,71], in addition to other connexins,
including Cx30 [3,72], Cx47 [2], Cx40, Cx45, Cx46 and
Cx26 [73]. Moreover, gap junctions provide a substrate for
formation of a functional astrocytic syncytium [70,71,74,75], implicated in the spatial buffering capacity of
astrocytes, particularly in dealing with extracellular K+
arising from neuronal activity [76,77]. The propagation of
intercellular Ca2 + waves is an important feature of astro-
cytes in response to activation [78]. Studies from several
laboratories have shown that gap junctions are involved in
mediating intercellular Ca2 + signaling throughout the glial
syncytium [79–81]. Astrocytic hemichannels also play a
role in the release of adenosine triphosphate (ATP) associ-
ated with Ca2 + signaling [82,83]. Moreover, the inhibition
of glycolytic and oxidative metabolism resulted in an
increase of astrocytic hemichannels [84], suggesting in-
volvement of hemichannels in this pathological condition.
Astrocytes cultured from Cx43 knockout mice exhibit
reduced gap junctional coupling and Ca2 + wave propagation
[85,86]. Meanwhile, Cx43 knockout astrocytes express other
connexin subtypes (Cx30, 40, 45, 26, 46) [73], suggesting
that connexins other than Cx43 could not compensate for the
reduction of GJIC in astrocytes. Even astrocytes derived
from heterozygote Cx43 knockout mice showed a significant
reduction in gap junctional coupling [85,87]. These hetero-
zygote mice have been used for in vivo studies (see below).
Recently, mice lacking Cx43 specifically in astrocytes have
been generated by using the cre-recombinase system [88].
These mice can survive to adulthood, unlike Cx43 knockout
mice, and exhibit amplified motor activity with increased
hippocampal spreading depression, providing a valuable
model for in vivo studies. Although Cx30 has been shown
only in astrocytic gap junctions in the CNS, no major
abnormality was observed in the brains of Cx30-deficient
mice, although they exhibit severe hearing loss [89].
2.3. Microglia
Microglia are important cells in the CNS, participating in
the reactive gliosis. Although resting microglia do not show
phagocytosis, activated microglia behave like phagocytes
[90]. Under normal conditions, microglia show little expres-
sion of Cx43, however, this increases following stimulation
by inflammatory cytokines [91] or Ca2 + ionophores [92],
allowing for enhancement of gap junctional coupling. Cx36
has been also found to form gap junctions in microglia [5],
suggesting the direct communication between microglia.
Moreover, brain macrophages/microglia decrease Cx43 ex-
pression and gap junctional coupling in co-cultured astro-
cytes [93,94]. It is important not only to understand the
phagocytic function of microglia but also to understand the
role of microglial gap junctions in the inflammatory re-
sponse of the CNS.
2.4. Oligodendrocytes
Several reports have indicated that oligodendrocyte gap
junctions are composed of Cx32 [95–100], Cx36 [5], Cx29
[101] and Cx47 [102]. We have shown that expression of
Cx32 coincides with maturation of oligodendrocytes tem-
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in oligodendrocytes is thought to be primarily metabolic to
allow ions and nutrients to pass from the somata to all the
layers of the myelin [104,105]. The importance of this
channel has recently been realized by the reported mutations
of Cx32 associated with X-linked Charcot–Marie–Tooth
disease, a peripheral demyelinating disorder [106–110]. It
was initially thought that human and rodent Schwann cells
are susceptible to pathology, leading to peripheral nerve
demyelination, while oligodendrocytes appeared not to be
affected. Cx32 knockout mice showed a reduced myelin
volume and an enhanced excitability in the CNS [57], and a
progressive peripheral neuropathy has been observed after 3
months of age [55,56]. Cx29 has also been specifically
observed in oligodendrocytes and Schwann cells [101]. The
expression of Cx29 exists mainly at the paranodes and
juxtaparanodes [101], whereas Cx32 is not observed in the
paranodes [111], indicating a difference in the distribution
of these two connexins. In the pathogenesis of demyelin-
ation associated with the Cx32 deficiency, the compensatory
role of Cx29 may have to be explored.
Recently, Cx47 was observed to be expressed mainly in
oligodendrocytes [102]. Cx47 null mice exhibit degenera-
tion of nerve fibers, particularly in the optic tract [102].
Moreover, Cx47 and Cx32 double knockout mice exhibited
a more severe demyelination in the CNS [102,112], indi-
cating that both connexins play a critical role in myelination.3. The role of gap junctions in neuropathological
conditions
3.1. Brain ischemia
Cerebrovascular diseases rank as the third leading cause
of death in the USA and fourth in Canada, most commonly
manifesting as ischemic brain stroke [113,114]. In the
context of experimental brain ischemia models, the neuro-
protective role of astrocytic gap junctions is still controver-
sial. Blocking astrocytic gap junctions enhances neuronal
vulnerability to glutamate cytotoxicity in culture [115].
Moreover, blocking gap junctions in a hippocampal slice
culture enhanced neuronal damage under experimental is-
chemia using oxygen and glucose depletion [116]. In vivo,
heterozygote Cx43 knockout mice showed a significantly
increased stroke volume compared to wild-type mice fol-
lowing middle cerebral artery occlusion (MCAO) [87] and
exhibited enhanced apoptosis in the penumbra [117]. These
results suggest that astrocytic gap junctions play a neuro-
protective role in oxidative and metabolic stress. On the
other hand, neuronal death caused by oxygen and glucose
depletion was decreased when Cx43 was blocked by specific
antisense oligodeoxynucleotide in the hippocampal slice
culture [118]. Similarly, the stroke volume following MCAO
in the rat model was reduced by blocking gap junctions using
octanol [119]. Therefore, it has been suggested that thespreading depression caused by ischemic insult goes through
astrocytic gap junctions which remain open during the
ischemic condition, resulting in the expansion of the stroke
volume [120]. However, there are problems in interpreting
the results obtained with gap junction blockers such as
octanol because of the lack of specificity, particularly when
administered systemically. In addition, there is no selectivity
with regard to astrocytic gap junctions since all gap junctions
in the tissue are affected. The use of more specific
approaches to target gap junctions is desirable, for example
using Cx43 antisense and interfering RNA. More recent use
of targeted deletion of connexins, specifically in astrocytes,
is providing evidence that astrocytic gap junctions play a
neuroprotective role in ischemic insults through reduction of
apoptosis and inflammation [121].
The role of astrocytic hemichannels in ischemic insult is
still unknown. Recently, it has been reported that astrocytic
hemichannels, which are closed under normal conditions,
remained open under experimental ischemia induced by
glucose and oxygen depletion [84]. It is possible that open
hemichannels allow for the release of glutamate causing loss
of membrane potential [122], or hemichannels may contrib-
ute to the distribution of anti-apoptotic factors in the lesion
area [123].
Cx32 knockout mice have been reported to exhibit an
enhanced vulnerability of hippocampal neurons against brief
global brain ischemia compared to wild-type mice [124],
suggesting that gap junctions of hippocampal interneurons
play a neuroprotective role in ischemic insults. Moreover,
expression of astrocytic gap junctions can be affected by
macrophages [93,94] and microglia express Cx43 following
activation [91]. In this context, the regulation of connexin
expression can be mediated by various types of cells other
than neurons and astrocytes following ischemic stress.
3.2. Epilepsy
There are two major clinical symptoms of epilepsy: the
partial seizure where excessive electrical discharge is re-
stricted to a given area in the brain, and the general seizure
involving the entire brain [125]. The pathogenesis of seiz-
ures may be associated with abnormal stimulation occurring
in a certain region of the brain causing depolarization of the
membrane, expanding to the surrounding cells. Gliosis at
the lesion is usually observed in epileptic brain tissue.
However, the participation of Cx43 which composes mainly
astrocytic gap junctions is controversial (reviewed in Ref.
[17]).
In models of experimental epilepsy, strong recurrent
excitatory activity, such as that produced by GABA receptor
blocking, K+ pump blocking, and repetitive stimulation is
used as the epileptic trigger [126]. Electrical coupling
through neuronal gap junctions is reported to play an
important role in the expansion of the epileptic wave
[127]. Blocking of astrocytic gap junctions decreases Ca2 +
oscillations in co-cultured neurons [128]. An increase of
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model of bicuculline-induced epileptiform activity [129],
although a decrease in the level of Cx36 mRNA has been
reported in the hippocampus of the kainate-treated rat [130].
Meanwhile, neuronal gap junctions are required for the
appearance of very fast oscillations associated with seizure
activity [18]. Cx43 mRNA levels were increased in the
temporal cortex of epilepsy patients [131]. Therefore, the
role of gap junctions in epilepsy is still controversial. In the
future, the gap junctional coupling between various types of
cells in vivo should be evaluated under epileptic stimulation.
3.3. Neurodegenerative disease
One of the major neurodegenerative diseases is Alzheim-
er’s disease (AD). Clinically, cerebral atrophy is observed
mainly in the frontal cortex of AD patients and pathological-
ly, neurofibrillary degeneration and senile plaques are shown
in the lesions [132]. The senile plaque is a round deposit
composed of h-amyloid protein surrounded by astrocytic
processes. An increase in the expression of Cx43 was
observed at the site of these amyloid plaques [15]. Patholog-
ical evaluations have revealed the importance of astrocytic
participation in the lesion using presenilin mutant knockin
mice [133,134] and apoE null mice [135–137]. However,
there is no report clarifying the relation between gap junctions
and AD. AD is a progressive disease and the lesion exhibits a
successive expansion, suggesting that the glial network may
play a critical role in the pathogenesis of AD.
Parkinson’s disease (PD) is a common neurodegenerative
disease. Clinical symptoms are progressive tremor, muscle
rigidity and gait disturbance [132]. In the brain of PD
patients, the loss of dopaminergic neurons is observed in
the substantia nigra-striatum [132]. The 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP)-model of PD exhibited
an increase of Cx43 expression in the striatum, although the
coupling of astrocytes was not increased [16]. The alteration
of gap junctions in the brains of PD patients has not yet been
reported. Therefore, the pathological role of gap junctions in
PD is still ambiguous. Although most of the mechanisms of
tremors and dyskinesias which are commonly observed in
PD patients are still obscure, the inferior olive has been
focused on as the pathological generator of tremors
[138,139]. Neurons of the inferior olive are electrically
coupled through gap junctions which plays a role in creating
oscillatory activity [140]. Some studies have reported that
the GJIC of inferior olive neurons is responsible for tremors
[139,140], however, no difference of the severity of tremor
induced by harmaline was observed between Cx36 knock-
out mice and wild-type mice [141]. More experiments will
be required to clarify the mechanism of tremors.
In neurodegenerative diseases, it is also important to
evaluate the inflammatory response because both AD and
PD exhibit inflammation in the lesion [142]. Indeed, anti-
inflammatory drugs may reduce the incidence of AD and
delay the progression of the disease [143,144]. As men-tioned previously, activated microglia express gap junctions
composed of Cx43 [91]. Moreover, activated macrophages
decreased the expression of astrocytic gap junctions [93,94].
Therefore, further investigation of the possible gap junc-
tional neuroprotective role of glial cells and inflammatory
cells in neurodegenerative diseases is warranted.
3.4. Tumor
Glioma is the most common brain tumor [145]. The
severity of gliomas is divided into four categories, from
most malignant tumor to benign tumor. In general, glioma is
a space-occupying mass in the brain and causes a high
intracranial pressure, vessel occlusion and brain edema
[145]. Investigating the tumor tissue has revealed that higher
grade gliomas express lower levels of Cx43 [146,147].
However, the relation between gap junctions in tumor cells
and metastasis is still ambiguous.
Up-regulated gap junctions reduce the in vitro prolifer-
ation of C6 glioma cells [148]. On the other hand, glioma
cells aggregate and invade into the astrocytic syncitia using
gap junctions [19]. Astrocytes co-cultured with C6 glioma
cells overexpressing Cx43 underwent phenotypic transfor-
mation [149], suggesting that tumor cells may affect phe-
notypical alteration of surrounding tissue through gap
junctions. The results obtained from in vitro studies are
remained controversial.
Gene transduction is a potential strategy for glioma
treatment [150]. Gap junctions of glioma cells may play a
critical role in the mechanism of this therapy. Glioma cells
infected with the herpes simplex virus thymidine kinase gene
can be killed upon exposure to ganciclovir. Neighboring
glioma cells that are intercellularly linked to the targeted cell
subsequently die due to a ‘‘bystander effect’’ [151]. The lethal
‘‘bystander effect’’ can be enhancedwhen the glioma cells are
forced to express Cx43 [152]. So far, the gap junctional role in
the ‘‘bystander effect’’ remains ambiguous, and further
investigations should be performed to discover the precise
mechanism of gap junctions involved in glioma therapy.
Recently, several reports have described that Cx43 plays
a role in suppressing tumor growth independent of gap
junction formation [153–155]. In this case, Cx43 trans-
fected into glioblastoma cells reduced cell proliferation
without enhancing gap junctional coupling, suggesting that
Cx43 acts as a tumor suppressor gene in human glioblasto-
ma [156]. The C-terminal domain of Cx43 seems to be
important in this tumor-inhibiting effect [154]. Cx43 may
also regulate the cell cycle by acting on the S-phase kinase-
associated protein [155]. Additional research may still need
to explore the tumor suppressing role of Cx43.4. Conclusions
The function of gap junctions and the difference of the
connexins have been well studied in the CNS. Neuronal gap
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periodic synchronized activity between neurons. Astrocytes
exchange ions and metabolic substrates, such as inositol
1,4,5-triphosphate and ATP, through gap junctions. Gap
junctions of oligodendrocytes play a critical role in main-
taining normal myelination. Moreover, the ischemic brain
models or epilepsy models using various connexin knockout
mice have revealed the possibility of neuronal protection of
gap junctions against ischemic or metabolic stress, although
opposite results have also been reported. Recent studies
have described that macrophages may influence the expres-
sion of astrocytic gap junctions and that activated microglia
may communicate with each other through gap junctions. It
is important to be able to understand the gap junctional
network in the entire neuronal system in the pathological
condition. Then, the regulation of gap junctions in the
nervous system may contribute to the development of new
therapies for neurological diseases.Acknowledgements
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